Literature DB >> 31942676

Dry Needling as a Treatment Modality for Tendinopathy: a Narrative Review.

Vladimir Stoychev1,2, Aharon S Finestone3, Leonid Kalichman4.   

Abstract

PURPOSE OF REVIEW: Tendinopathy describes a combination of pain, swelling, and impaired performance of the tendon and around structures. There are various treatment options for tendinopathy with unclear efficacy. Dry needling involves inserting needles into the affected tendon, and it is thought to disrupt the chronic degenerative process and encourage localized bleeding and fibroblastic proliferation. The purpose of this review is to review the use of dry needling as a treatment modality for tendinopathy. RECENT
FINDINGS: The effectiveness of dry needling for treatment of tendinopathy has been evaluated in 3 systematic reviews, 7 randomized controlled trials, and 6 cohort studies. The following sites were studied: wrist common extensor origin, patellar tendon, rotator cuff, and tendons around the greater trochanter. There is considerable heterogeneity of the needling techniques, and the studies were inconsistent about the therapy used after the procedure. Most systematic reviews and randomized controlled trials support the effectiveness of tendon needling. There was a statistically significant improvement in the patient-reported symptoms in most studies. Some studies reported an objective improvement assessed by ultrasound. Two studies reported complications. Current research provides initial support for the efficacy of dry needling for tendinopathy treatment. It seems that tendon needling is minimally invasive, safe, and inexpensive, carries a low risk, and represents a promising area of future research. In further high-quality studies, tendon dry needling should be used as an active intervention and compared with appropriate sham interventions. Studies that compare the different protocols of tendon dry needling are also needed.

Entities:  

Keywords:  Acupuncture; Dry needling; Needle tenotomy; Tendinopathy; Tendon fenestration

Year:  2020        PMID: 31942676     DOI: 10.1007/s12178-020-09608-0

Source DB:  PubMed          Journal:  Curr Rev Musculoskelet Med        ISSN: 1935-9748


  7 in total

1.  Percutaneous ultrasonic tenotomy with the TX-1 device versus surgical tenotomy for the treatment of common extensor tendinosis.

Authors:  Faysal Altahawi; Xin Li; Brittani Demarest; Michael C Forney
Journal:  Skeletal Radiol       Date:  2020-07-09       Impact factor: 2.199

Review 2.  Narrative: Review of Anterior Knee Pain Differential Diagnosis (Other than Patellofemoral Pain).

Authors:  Anne Kuwabara; Michael Fredericson
Journal:  Curr Rev Musculoskelet Med       Date:  2021-04-05

3.  Effects of focused ultrasound and dry needling on tendon mechanical properties.

Authors:  Sujata Khandare; Molly Smallcomb; Ali A Butt; Jacob Elliott; Julianna C Simon; Meghan E Vidt
Journal:  J Biomech       Date:  2021-12-22       Impact factor: 2.712

Review 4.  The effectiveness of percutaneous ultrasound-guided needle tenotomy compared to alternative treatments for chronic tendinopathy: a systematic review.

Authors:  Firoozeh Shomal Zadeh; Mehrzad Shafiei; Nastaran Hosseini; Ehsan Alipour; Hoiwan Cheung; Majid Chalian
Journal:  Skeletal Radiol       Date:  2022-07-28       Impact factor: 2.128

5.  Comparative Effect of Dry Needling and Neural Mobilization on Pain, Strength, Range of Motion, and Quality of Life in Patients With Lateral Epicondylitis: Protocol for Randomized Clinical Trial.

Authors:  Riya Gupta; Aksh Chahal
Journal:  J Chiropr Med       Date:  2021-12-15

6.  Physical Therapy Interventions for the Management of Biceps Tendinopathy: An International Delphi Study.

Authors:  Amy W McDevitt; Joshua A Cleland; Simone Addison; Leah Calderon; Suzanne Snodgrass
Journal:  Int J Sports Phys Ther       Date:  2022-06-01

Review 7.  Molecular and Structural Effects of Percutaneous Interventions in Chronic Achilles Tendinopathy.

Authors:  Christelle Darrieutort-Laffite; Louis J Soslowsky; Benoit Le Goff
Journal:  Int J Mol Sci       Date:  2020-09-23       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.